A Non-Randomised Open-Label Exploratory ‘window of Opportunity’ Study of TG02 Treatment in Patients with Locally Advanced Primary and Recurrent RAS Mutant Colorectal Cancer
Heliyon(2024)
Key words
Colorectal cancer,Cancer Vaccine,KRAS,TG02,GM-CSF
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined